Institut de Cancérologie du Gard

Nîmes 30029

1 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Non-small-Cell Lung, MDS, Myelodysplastic Syndrome, RAEB, Refractory Anemia With Excess Blasts, Urothelial Cancer

Studies at this site

• A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer — Recruiting now
• A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations — Running, not enrolling
• Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA — Stopped early